anastomotic stenosis of choledochojejunostomy or pancreaticojejunostomy
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who achieved technical and clinical success for choledochojejunostomy or pancreaticojejunostomy by BAE-ERCP, and could be followed up for more than 6 months after the initial treatment, patients over 20 years of age
Exclusion criteria
Exclusion criteria: Patients with malignant anastomotic stenosis or those who underwent therapeutic procedures except BAE, such as the EUS-guided or percutaneous approach, in the initial treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Choledocojejunostomy and pancreaticojejunostomy recurrence rates after the initial treatment using balloon-assisted endoscopy for anastmotic stenosis | — |
Secondary
| Measure | Time frame |
|---|---|
| Initial therapy details for choledocojejunostomy or pancreaticojejunostomy, initial therapy complications, treatment details for choledocojejunostomy or pancreaticojejunostomy recurrence | — |
Countries
Japan
Contacts
Teine-Keijinkai Hospital Center for Gastroenterology